Search
-
-
New#GreenInnovationForum | “It is a key platform to showcase how biotechnology can be an esse...
We interviewed Ángel Antelo Domínguez, LCMS Specialist at Agilent Technologies, Silver Sponsor of the Green Innovation Forum 2024.
-
NewThe data revolution and AI in the Health sector
The data and artificial intelligence revolution is driving deep changes in medical research.
-
New"25 Years at the Heart of the Sector": AseBio highlights key milestones in an infographic ...
“AseBio has been and will continue to be a catalyst for innovation, so let’s keep working together to ensure that, over the next 25 years, biotechnology remains a cornerstone of our society and a
-
New#GreenInnovationForum | “To move toward net-zero emissions in healthcare, at AstraZeneca w...
We interviewed Marta Moreno, Director of Corporate Affairs and Market Access at AstraZeneca Spain, Bronze Sponsor of the 2024 Green Innovation Forum.
-
NewThe Fight Against Pneumonia and Antibiotic Resistance: Vaxdyn and the K-Vax Vaccine Candid...
On the occasion of World Pneumonia Day, we interviewed Juanjo Infante, CEO of Vaxdyn, a biotech company developing the K-Vax vaccine candidate against Klebsiella pneumoniae, which is responsible for
-
NewThe Green Innovation Forum is a great opportunity to raise awareness of important issues ...
We interviewed Christine Kolland, Business Development Iberia & Latin America at ZETA, Bronze Sponsor of the Green Innovation Forum
-
NewAccess to Innovative Therapies in Spain: Challenges and Opportunities
In this article, Chus Castillo, Partner Consulting Iberia at Alira Health, and Ion Arocena, General Manager at AseBio, explore the innovative therapies landscape in Spain, existing barriers, and
-
New“We hope that the Green Innovation Forum will create business opportunities, foster intern...
We interviewed Iñaki Larraya, Managing Director of Sodena, the public entity of the Government of Navarra organizing the upcoming edition of the Green Innovation Forum in Pamplona alongside AseBio.
-
NewBarcelona establishes itself as the host city for BIOSPAIN for the 2025 and 2027 editions
In its 12th edition, the event is expected to gather over 2,000 professionals from more than 1,000 organizations working in health, agri-food, and sustainable industrial solutions from October 7 to 9
-
NewCaszyme and Integra Therapeutics sign licensing agreement for novel CRISPR Cas12l nucleas...
The agreement was unveiled at this year’s BIO Europe, which is the largest partnering event for the biomedical industry in Europe, taking place this week in Stockholm. Over 2,800 companies attended
-
NewThe Green Innovation Forum 2024 Will analyze the key role of biotechnology in the transiti...
The Green Innovation Forum 2024 is a must-attend event for companies, foundations, and academic institutions in the biotechnology field, as well as for companies and institutions from other industrial
-
NewMikrobiomik celebrates the first Investor's Day: presents clinical and corporate progress
El pasado 24 de octubre, Mikrobiomik celebró su primer Investor´s Day, reuniendo a profesionales del sector farmacéutico y biotecnológico, socios e inversores. En la jornada se compartieron logros
-
NewSunLabs and MERLIN Properties Sign Exclusive Commercialization Agreement Over 5,000 Square...
The new SunLabs facility will be a cutting-edge life sciences research and development hub.
-
-
NewINBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer In...
VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation Council) and continued support from existing investors Asabys Partners and Aliath
-
NewMenarini and the Germans Trias i Pujol Research Institute sign an agreement to promote res...
The organisations are collaborating on two studies in the field of severe Legionella infections and antibiotic resistance.
-
-
-
NewORYZON reports financial results and corporate update for quarter ended September 30, 2024
Final data from PORTICO, global Phase IIb vafidemstat trial in BPD,presented at the 37th ECNP annual conference in September
-